Literature DB >> 1279987

Modulation of tumor necrosis factor-induced increase in renal (LLC-PK1) transepithelial permeability.

J M Mullin1, K V Laughlin, C W Marano, L M Russo, A P Soler.   

Abstract

Tumor necrosis factor-alpha (TNF) causes a spontaneously reversible increase in tight junction permeability. TNF was the only cytokine tested that produced this effect. The effect on transepithelial permeability proceeds in four distinct phases: 1) a 60- to 90-min delay from time of application of TNF, 2) a rapid decrease in transepithelial resistance, 3) a recovery of transepithelial resistance to control level within 1 h, and 4) a further increase of transepithelial resistance above control levels. The recovery of transepithelial resistance occurs with or without TNF in the culture medium. Different protein kinase inhibitors affected different phases of this overall process. The tyrosine kinase inhibitor genistein significantly blocked the TNF effect. Neither transcription nor protein synthesis was required for transepithelial permeability to increase, but were required for the recovery. After the tight junctions have opened at 2 h in response to TNF, a second application of TNF will not produce the effect again for at least 12 h. The tight junctions will, however, open in response to phorbol esters during this time frame. Electron microscopy studies using apically applied ruthenium red suggest that TNF action results in < 10% of the junctions having increased permeability at any given time during the resistance decrease. The role of epithelial barrier permeability changes in TNF action in vivo is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1279987     DOI: 10.1152/ajprenal.1992.263.5.F915

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  20 in total

Review 1.  Tight junctions on the move: molecular mechanisms for epithelial barrier regulation.

Authors:  Le Shen
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

Review 2.  Tight junction pore and leak pathways: a dynamic duo.

Authors:  Le Shen; Christopher R Weber; David R Raleigh; Dan Yu; Jerrold R Turner
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

3.  Ras mutation impairs epithelial barrier function to a wide range of nonelectrolytes.

Authors:  James M Mullin; James M Leatherman; Mary Carmen Valenzano; Erika Rendon Huerta; Jon Verrechio; David M Smith; Karen Snetselaar; Mantao Liu; Mary Kay Francis; Christian Sell
Journal:  Mol Biol Cell       Date:  2005-09-21       Impact factor: 4.138

Review 4.  Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application.

Authors:  Jerrold R Turner
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

Review 5.  Intestinal barrier function: molecular regulation and disease pathogenesis.

Authors:  Katherine R Groschwitz; Simon P Hogan
Journal:  J Allergy Clin Immunol       Date:  2009-07       Impact factor: 10.793

Review 6.  Intestinal mucosal barrier function in health and disease.

Authors:  Jerrold R Turner
Journal:  Nat Rev Immunol       Date:  2009-11       Impact factor: 53.106

Review 7.  Cytokine regulation of epithelial permeability and ion transport.

Authors:  D M McKay; A W Baird
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

8.  Critical role for P-glycoprotein expression in hematopoietic cells in the FVB.Mdr1a(-/-) model of colitis.

Authors:  Elizabeth M Staley; Reed A Dimmitt; Trenton R Schoeb; Scott M Tanner; Robin G Lorenz
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-12       Impact factor: 2.839

9.  Sieving characteristics of cytokine- and peroxide-induced epithelial barrier leak: Inhibition by berberine.

Authors:  Katherine M DiGuilio; Christina M Mercogliano; Jillian Born; Brendan Ferraro; Julie To; Brittany Mixson; Allison Smith; Mary Carmen Valenzano; James M Mullin
Journal:  World J Gastrointest Pathophysiol       Date:  2016-05-15

10.  Differential cellular immunolocalization of renal tumour necrosis factor-alpha production during ischaemia versus endotoxaemia.

Authors:  K K Donnahoo; X Meng; L Ao; A Ayala; B D Shames; M P Cain; A H Harken; D R Meldrum
Journal:  Immunology       Date:  2001-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.